Stylet Shape in Simulated Endotracheal Intubation by Medical Students
Launched by NATIONAL UNIVERSITY HOSPITAL, SINGAPORE · Jul 24, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the best shape of a tube used for endotracheal intubation, which is a procedure that helps people breathe when they cannot do so on their own. The goal is to find out which tube shape makes it easier for medical students to successfully perform this important procedure during their training.
If you are a final-year medical student at the Yong Loo Lin School of Medicine in Singapore and are participating in a simulation training, you may be eligible to join this study. Participants will practice intubation techniques using different tube shapes and provide feedback on their experiences. This trial is open to all genders and aims to improve the training process for future doctors, ultimately enhancing patient care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Final year medical students in the Yong Loo Lin School of Medicine, National University of Singapore, undergoing their simulation posting. Endotracheal intubation is a procedure that is taught during this posting.
- Exclusion Criteria:
- • Injuries precluding performance of endotracheal intubation. Non exhaustive examples include arm injuries.
About National University Hospital, Singapore
National University Hospital (NUH) in Singapore is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, NUH emphasizes a multidisciplinary approach, integrating cutting-edge medical research with high-quality patient care. The hospital collaborates with various stakeholders, including academic institutions and industry partners, to explore new therapies and improve treatment outcomes across a wide range of medical disciplines. Committed to ethical standards and patient safety, NUH plays a pivotal role in shaping the future of medicine in Singapore and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Trial Officials
Matthew JW Low, MBBS
Principal Investigator
National University Hospital, Singapore
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported